More money found it’s way out of the large cap indexes, moving into midcaps, biotechs and select leading names. Trading volume was light as the day was pretty slow. Leading stocks continue to outperform without flashing buy signals. Some of the outperformance is simply holding steady as the indexes sag. The biotech indexes, on the other hand, remain in strong uptrends. I’m trying to build a stronger buy list while things consolidate here.
My allocation accounts remain in MDY, which outperformed smartly on the day.